MoonLake Immunotherapeutics

NASDAQ:MLTX

38.55 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020
Assets:
Current Assets:
Cash & Cash Equivalents 180.426451.16939.5068.0391.336
Short Term Investments 267,600.959.83932.60900
Cash and Short Term Investments 448,027.349511.00872.1158.0391.336
Net Receivables 2.8431.0570.2170.1490
Inventory 0001.3220
Other Current Assets 23,418.2982.1024.1791.4490.283
Total Current Assets 474,288.845514.16776.5119.6371.619
Non-Current Assets:
Property, Plant & Equipment, Net 3.6443.9490.3320.0460
Goodwill 00000
Intangible Assets 00000
Goodwill and Intangible Assets 00000
Long Term Investments 000115.043115.015
Tax Assets 00000
Other Non-Current Assets 3,640.7938.423-0-115.0430
Total Non-Current Assets 3,644.43712.3730.3320.046115.015
Total Assets 477,933.282526.5476.8439.682116.634
Liabilities & Equity:
Current Liabilities:
Account Payables 8.67800.0471.2330
Short Term Debt 1.3721.3060.154150.058
Tax Payables 0.6420.3680.110.0640
Deferred Revenue 00000
Other Current Liabilities 22,453.1698.2927.3554.7910.067
Total Current Liabilities 22,463.8619.9667.66521.0880.125
Non-Current Liabilities:
Long Term Debt 1.4582.50.12900
Deferred Revenue Non-Current 00000
Deferred Tax Liabilities Non-Current 00000
Other Non-Current Liabilities 2,076.8240.5830.2820.244.025
Total Non-Current Liabilities 2,078.2823.0830.4110.244.025
Total Liabilities 24,542.14313.0498.07721.3274.15
Equity:
Preferred Stock 0000.0720
Common Stock 0.0060.0060.0050.039115
Retained Earnings -235,592.989-116.657-80.65-53.644-2.517
Accumulated Other Comprehensive Income/Loss 4.9972.3580.351-0.1680
Other Total Stockholders Equity 682,412.988609.969129.19242.0560
Total Shareholders Equity 446,825.002495.67648.898-11.645112.484
Total Equity 446,831.568513.49168.767-11.645112.484
Total Liabilities & Shareholders Equity 477,933.282526.5476.8439.682116.634